2014 Annual Meeting | 8SM.001 - Mitochondrial Disorders in Neurology

Date Saturday 05/03/14

Time 10:00 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Salvatore DiMauro, MD

Topic(s)

Learning Objectives Participants should be familiar with recent progress in mitochondrial genetics; gain a better understanding of the relationships, which are not always straightforward, between mutations in either genome (mtDNA or nDNA) and clinical presentations; learn useful clues to the correct diagnosis; glean ideas about pathogenesis (energy shortage, oxidative stress); and get a realistic understanding of palliative and experimental therapy.

CME Available No CME available

Recommended Audience Trainee, General Neurologist

Teaching Styles Didactic

Event Timeline
10:00 AM - 10:30 AM		Genetics and Pathogenesis of Mitochondrial Diseases Eric A. Schon, PhD
10:30 AM - 10:40 AM		Questions and Answers
10:40 AM - 11:10 AM		Clinical Presentations of Mitochondrial Diseases Michio Hirano, MD, FAAN
11:10 AM - 11:20 AM		Questions and Answers
11:20 AM - 12:00 PM		Representative Case Descriptions Michio Hirano, MD, FAAN

Faculty Disclosures
Salvatore DiMauro, MD	No disclosure on file
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics (a subsidiary of Zogenix). Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Innovation Specialist. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Platform Q Health. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Modis Therapeutics (a subsidiary of Zogenix. The institution of Dr. Hirano has received research support from Cyclerion. Dr. Hirano has received research support from Reneo Pharmaceuticals. The institution of Dr. Hirano has received research support from Astellas. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Eric A. Schon, PhD	Dr. Schon has nothing to disclose.